Skip to content

Thomas LEPERS - Anesthésie

Active
Private limited companyfounded 2024active for 2 yearsBosquetstraat 72, 1060 Sint-Gillis (bij-Brussel), BelgiumKBO/BCE: BE 1015.005.624
Summary

Thomas LEPERS - Anesthésie has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €283,217 and a net result of €281,217. Its solvency ranks better than 64% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Thomas LEPERS - AnesthésieActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €590,000turnover 2025, estimated
Equity
€283,217
Profit
€281,217
Turnover estimated from the gross margin
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 44 days early
Why 97raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.32, cash €81,590Figures for financial year 2025 (filed 17-06-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 73% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 100
equity 75.2% of total assets
Liquidity 75
short-term debt 13.1% · cash 21.7%
Profitability 100
return on assets 74.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2025: 0.6% 12-2025: 0.7%▲ +0.1 percentage points vs 11-2025 01-2026: 0.7%● unchanged vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.8%▲ +0.1 percentage points vs 05-2026highest value 07-2026: < 0.1%▼ -0.8 percentage points vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 6.32, above the usual 1.5; short-term debt: 13.1% and cash: 21.7% of total assets), and 24.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 57% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.32, cash €81,590
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed 17-06-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
44 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Registered officeRegistered-office move
  3. IncorporationAppointment: LEPERS Thomas, Gilbert, Denis…

Key points

  • Positive: Among the best 6% on net resultsector median €60,202 · 20,607 companies €281,217 View
  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €376,554 View

By topic

Financials

Financial year
2025
Total assets
€376,554
Profit
€281,217
Solvency
75.2%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
11-10-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
38
Annual meeting
First Friday of June at 18:00
Purpose
“En assurant la gestion d'un centre médical ou d'un cabinet médical, en ce compris…” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about Thomas LEPERS - Anesthésie

What is the company number of Thomas LEPERS - Anesthésie?
1015.005.624. In Belgium the VAT number is the company number with BE in front: BE 1015.005.624.
Where is Thomas LEPERS - Anesthésie based?
The registered office is at Bosquetstraat 72, 1060 Sint-Gillis (bij-Brussel).Company details
What does Thomas LEPERS - Anesthésie do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Thomas LEPERS - Anesthésie?
Private limited company (BV).
When was Thomas LEPERS - Anesthésie founded?
On 11-10-2024.
Is Thomas LEPERS - Anesthésie still active?
Yes, Thomas LEPERS - Anesthésie is an active enterprise in the KBO register.
What is the turnover of Thomas LEPERS - Anesthésie?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Thomas LEPERS - Anesthésie profitable?
In financial year 2025, Thomas LEPERS - Anesthésie made a profit of €281,217.
Where can I find the annual accounts of Thomas LEPERS - Anesthésie?
Thomas LEPERS - Anesthésie filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to Thomas LEPERS - Anesthésie

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure